Trial Profile
Long term prsopective study of ultrasound-guided BoNT-A injections for severe sialorrhea secondary to neurological dysphagia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Sialorrhoea
- Focus Adverse reactions; Therapeutic Use
- 25 Oct 2016 New trial record